HMN 2025: How to Probe the molecular mechanisms of metastasis

Cells have a mailing system of types. They can launch tiny molecular balls, referred to as extracellular vesicles (EVs), that comprise organic matter or messages and connect to different cells to share no matter they comprise.

In cancer, EVs typically depart from tumor cells to seed the cancer elsewhere within the physique, resulting in metastasis. However, how the EVs related to recipient cells to ship their payload has remained a thriller—till now. A workforce of researchers based mostly in Japan has revealed the molecular mechanisms underpinning the method for small EVs (sEVs), which they mentioned might have implications for creating higher cancer therapies.

The workforce published their findings within the Journal of Cell Biology.

“In latest years, EVs have garnered important consideration as mediators of intercellular communication,” mentioned corresponding writer Kenichi G.N. Suzuki, a professor on the Institute for Glyco-core Research at Gifu University in Gifu and a chief on the Division of Advanced Bioimaging, National Cancer Center Research Institute in Tokyo, Japan.

He defined that EVs can function biomarkers, since they carry particular proteins and genetic materials that may point out illness development. Researchers have additionally began to discover their potential to deal with cancers, both by inhibiting their binding to host cells or by encouraging the binding of EVs with therapeutic payloads.

“However, the mechanisms underlying their selective binding to recipient cell membranes have remained elusive,” Suzuki mentioned. “In this study, we sought to elucidate these mechanisms.”

The researchers targeted on understanding the function of integrin heterodimers, that are molecules that assist sEVs adhere to the host cell. The workforce beforehand discovered that sEVs might be sorted into subtypes with totally different properties, relying on which tetraspanin protein it has. This sort of protein is small however vital to EV formation and regulation, Suzuki mentioned.

Using this understanding, the researchers sorted and tracked the sEVs with single-molecule decision.

They examined the sorted subtypes with super-resolution microscopy to seek out that every one subtypes primarily used integrin heterodimers related to a particular tetraspanin protein often known as CD151 and a molecule containing carbohydrates and fat referred to as GM1 to bind to laminin, a protein vital to mobile membranes and closely concerned in cell membrane construction and cell adhesion, amongst different obligations.

Laminin is particularly a glycoprotein, that means it’s a protein with a carbohydrate, or sugar, molecule connected to it. It exists within the extracellular matrix, or the molecular community surrounding cells and helps their signaling and construction.

“Quantitative evaluation utilizing single-molecule imaging and super-resolution microscopy demonstrated that every one EV subtypes derived from 4 distinct tumor cell strains, no matter measurement, predominantly bind to laminin by way of CD151-associated integrin heterodimers and GM1, thereby eliciting responses in recipient cells,” Suzuki mentioned, noting that EVs sure to laminin considerably greater than they sure to fibronectin, which is one other protein answerable for cell adhesion within the extracellular matrix.

He additionally identified that two different proteins related to adhesion within the EVs, talin and kindlin, didn’t activate the integrin heterodimers. Taken all collectively, the researchers concluded that GM1 and integrin heterodimers related to CD151 are key for EV binding. This understanding, Suzuki mentioned, might assist researchers higher inhibit or encourage binding as wanted within the identify of illness therapy.

“While EVs have been extensively explored as biomarkers, makes an attempt to make use of EVs as therapeutic brokers have begun,” Suzuki mentioned. “Given our elucidation of the molecular mechanisms underlying EV binding to recipient cells, our findings are anticipated to advance the event of EV-based therapeutics.”